Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Depreciation & Amortization (CF) (2017 - 2025)

Crinetics Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 9 years, most recently at $994000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 26.14% year-over-year to $994000.0; the TTM value through Dec 2025 reached $3.9 million, up 39.68%, while the annual FY2025 figure was $3.9 million, 39.68% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $994000.0 at Crinetics Pharmaceuticals, down from $1.0 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.0 million in Q3 2025 and troughed at $215000.0 in Q2 2022.
  • A 5-year average of $483900.0 and a median of $280000.0 in 2022 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 6.52% in 2022 and later soared 200.76% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $235000.0 in 2021, then rose by 19.15% to $280000.0 in 2022, then decreased by 6.43% to $262000.0 in 2023, then soared by 200.76% to $788000.0 in 2024, then grew by 26.14% to $994000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for CRNX at $994000.0 in Q4 2025, $1.0 million in Q3 2025, and $959000.0 in Q2 2025.